share_log

Shenzhen Vital New Material's (SZSE:301319) Profits Appear To Have Quality Issues

Shenzhen Vital New Material's (SZSE:301319) Profits Appear To Have Quality Issues

深圳維塔爾新材料(深圳證券交易所代碼:301319)的利潤似乎存在質量問題
Simply Wall St ·  05/02 18:16

Following the solid earnings report from Shenzhen Vital New Material Co., Ltd. (SZSE:301319), the market responded by bidding up the stock price. However, we think that shareholders should be cautious as we found some worrying factors underlying the profit.

深圳世創新材料公司(SZSE:301319)發佈了紮實的收益報告後,市場反應是抬升股價。然而我們認爲股東應謹慎,因爲我們發現一些威脅利潤的因素。

earnings-and-revenue-history
SZSE:301319 Earnings and Revenue History May 2nd 2024
SZSE:301319營收及盈利歷史2024年5月2日

The Impact Of Unusual Items On Profit

除了稀釋之外,還應該注意的是,萬集科技在過去12個月中因不尋常項目獲得了價值人民幣3.5萬元的利潤。雖然我們希望看到利潤增加,但當這些不尋常項目對利潤做出重大貢獻時,我們會更加謹慎。我們對全球大部分上市公司的數據進行了分析,發現不尋常項目往往是一次性的。這正如我們所期望的那樣,因爲這些提升被描述爲"不尋常"。相對於其利潤而言,萬集科技在2021年12月前的不尋常項目貢獻大。因此,我們可以推斷出,這些不尋常項目正在使其財務利潤顯著增強。

To properly understand Shenzhen Vital New Material's profit results, we need to consider the CN¥14m gain attributed to unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. And that's as you'd expect, given these boosts are described as 'unusual'. If Shenzhen Vital New Material doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.

爲了透徹理解深圳世創新材料的利潤結果,我們需要考慮歸因於飛凡項目的1400萬元人民幣的收益。雖然高利潤總是美好的,但大量來自飛凡項目的貢獻有時會削弱我們的熱情。在我們分析了成千上萬個上市公司的數據後,我們發現在一年中由於異常項目而獲得提升的情況通常不會在下一年重複出現。鑑於這些提升都被描述爲“異常”,這是可以預料的。如果深圳世創新材料沒有看到這種貢獻的重複,那麼在其他條件不變的情況下,我們預計它的利潤會在當前年度下降。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓您想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看基於其估計的未來盈利能力的互動圖表。

Our Take On Shenzhen Vital New Material's Profit Performance

我們對深圳世創新材料的利潤表現的看法

Arguably, Shenzhen Vital New Material's statutory earnings have been distorted by unusual items boosting profit. Because of this, we think that it may be that Shenzhen Vital New Material's statutory profits are better than its underlying earnings power. Sadly, its EPS was down over the last twelve months. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. In terms of investment risks, we've identified 2 warning signs with Shenzhen Vital New Material, and understanding them should be part of your investment process.

可以說,深圳世創新材料的法定收益被通過提升利潤的非比尋常項目所扭曲。因此,我們認爲深圳世創新材料的法定利潤可能比其基本盈利能力更好。不幸的是,它的每股收益在過去十二個月內有所下降。歸根結底,如果您想正確地了解這家公司,除了上述因素之外,還需要考慮更多因素。因此,如果您想深入了解這隻股票,了解它面臨的任何風險至關重要。在投資風險方面,我們已經發現了深圳世創新材料存在兩個警示信號,理解它們應該成爲您投資過程的一部分。

Today we've zoomed in on a single data point to better understand the nature of Shenzhen Vital New Material's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

今天,我們聚焦於一個單一數據點,以更好地了解深圳世創新材料利潤的性質。但是,如果您能集中精力研究,總有更多可以發現的內容。有些人認爲股權回報率高是一家優質企業的一個好跡象。雖然可能需要您進行一些研究,但您可能會發現這個免費的高股權回報公司收藏夾或這個正在被內部人員收購的股票清單非常有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或電郵 editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論